换一批
换一批Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
作者：
Gerhardt,Attard [1]
;
Laura,Murphy [2]
;
Noel W,Clarke [3]
;
William,Cross [4]
;
Robert J,Jones [5]
;
Christopher C,Parker [6]
;
Silke,Gillessen [7]
;
Adrian,Cook [2]
;
Chris,Brawley [2]
;
Claire L,Amos [2]
;
Nafisah,Atako [2]
;
Cheryl,Pugh [2]
;
Michelle,Buckner [2]
;
Simon,Chowdhury [8]
;
Zafar,Malik [9]
;
J Martin,Russell [10]
;
Clare,Gilson [2]
;
Hannah,Rush [2]
;
Jo,Bowen [11]
;
Anna,Lydon [12]
;
Ian,Pedley [13]
;
Joe M,O'Sullivan [14]
;
Alison,Birtle [15]
;
Joanna,Gale [16]
;
Narayanan,Srihari [17]
;
Carys,Thomas [18]
;
Jacob,Tanguay [19]
;
John,Wagstaff [20]
;
Prantik,Das [21]
;
Emma,Gray [22]
;
Mymoona,Alzoueb [23]
;
Omi,Parikh [24]
;
Angus,Robinson [25]
;
Isabel,Syndikus [9]
;
James,Wylie [3]
;
Anjali,Zarkar [26]
;
George,Thalmann [27]
;
Johann S,de Bono [6]
;
David P,Dearnaley [6]
;
Malcolm D,Mason [28]
;
Duncan,Gilbert [2]
;
Ruth E,Langley [2]
;
Robin,Millman [2]
;
David,Matheson [29]
;
Matthew R,Sydes [2]
;
Louise C,Brown [2]
;
Mahesh K B,Parmar [2]
;
Nicholas D,James [6]
;
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators
作者单位：
Cancer Institute, University College London, London, UK; University College London Hospitals, London, UK. Electronic address: g.attard@ucl.ac.uk.
[1]
MRC Clinical Trials Unit at University College London, London, UK.
[2]
The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK.
[3]
St James's University Hospital, Leeds, UK.
[4]
Beatson West of Scotland Cancer Centre, Glasgow, UK.
[5]
Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.
[6]
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland.
[7]
Guy's and St Thomas' NHS Foundation Trust, London, UK.
[8]
Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
[9]
University of Glasgow Institute of Cancer Sciences, Glasgow, UK.
[10]
Cheltenham General Hospital, Cheltenham, UK.
[11]
Torbay and South Devon NHS Foundation Trust, Torbay, UK.
[12]
Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
[13]
Queen's University Belfast, Belfast, UK.
[14]
Royal Preston Hospital, Preston, UK.
[15]
Queen Alexandra Hospital, Portsmouth, UK.
[16]
Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK.
[17]
Kent Oncology Centre, Maidstone, UK.
[18]
Velindre Hospital, Cardiff, UK.
[19]
Singleton Hospital, Swansea, UK.
[20]
Royal Derby Hospital, Derby, UK.
[21]
Yeovil District Hospital NHS Foundation Trust, Yeovil, UK; Musgrove Park Hospital, Taunton, UK.
[22]
Weston Park Hospital, Sheffield, UK.
[23]
Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
[24]
Royal Sussex County Hospital, Brighton, UK.
[25]
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
[26]
Inselspital Universitatsspital Bern, Bern, Switzerland.
[27]
Cardiff University, Cardiff, UK.
[28]
Faculty of Education Health and Wellbeing, University of Wolverhampton, Walsall, UK.
[29]
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);苯甲酰胺类(Benzamides);化学疗法, 辅助(Chemotherapy, Adjuvant);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);无病生存(Disease-Free Survival);人类(Humans);男(雄)性(Male);多中心研究(主题)(Multicenter Studies as Topic);肿瘤复发, 局部(Neoplasm Recurrence, Local);腈类(Nitriles);苯硫乙内酰脲(Phenylthiohydantoin);泼尼松龙(Prednisolone);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.1016/S0140-6736(21)02437-5
PMID
34953525
发布时间
2024-02-10
- 浏览4
Lancet (London, England)
Lancet (London, England)
447-460页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
